PharmaCyte Biotech Ownership | Who Owns PharmaCyte Biotech?


OverviewFinancialsChart

PharmaCyte Biotech Ownership Summary


PharmaCyte Biotech is owned by 7.59% institutional investors, 8.56% insiders, and 83.85% retail investors. Hrt financial lp is the largest institutional shareholder, holding 2.69% of PMCB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.71% of its assets in PharmaCyte Biotech shares.

PMCB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPharmaCyte Biotech7.59%8.56%83.85%
SectorHealthcare Stocks 231.75%10.72%-142.47%
IndustryBiotech Stocks 382.34%10.54%-292.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hrt financial lp182.80K2.69%$132.00K
Geode capital management123.84K1.82%$89.67K
Renaissance94.04K1.38%$68.08K
Vanguard group74.92K1.10%$54.24K
Equitec proprietary markets82.73K1.08%$129.88K
Susquehanna group, llp34.48K0.45%$53.45K
Schonfeld strategic advisors26.20K0.39%$25.40K
Simplex trading25.83K0.38%$18.70K
Northern trust19.21K0.28%$18.62K
Jane street group11.39K0.17%$8.25K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Equitec proprietary markets82.73K0.13%$129.88K
Hrt financial lp182.80K0.00%$132.00K
Renaissance94.04K0.00%$68.08K
Tower research capital llc (trc)5.55K0.00%$5.38K
Planning capital management100.000.00%$196.00
Schonfeld strategic advisors26.20K0.00%$25.40K
Cwm---
Blackrock13.35K-$26.16K
Two sigma securities---
Mcf advisors1.00-$1.00

Top Buyers

HolderShares% AssetsChange
Hrt financial lp182.80K0.00%182.80K
Simplex trading25.83K-24.73K
Renaissance94.04K0.00%14.04K
Jane street group11.39K-11.39K
Tower research capital llc (trc)5.55K0.00%2.77K

Top Sellers

HolderShares% AssetsChange
K2 principal fund---209.27K
Two sigma securities---27.75K
Dimensional fund advisors lp---20.30K
Citadel advisors---8.56K
Blackrock13.35K--7.76K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp182.80K0.00%182.80K$132.00K
Jane street group11.39K-11.39K$8.25K
Planning capital management100.000.00%100.00$196.00
Accredited wealth management50.00-50.00$1.00K
Mcf advisors1.00-1.00$1.00

Sold Out

HolderChange
Citigroup-1.00
Koesten, hirschmann & crabtree-1.00
Jones financial companies lllp-2.00
Jpmorgan chase-16.00
Maryland capital advisors-35.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-36.36%515,59719.05%718.68%6-33.33%2-50.00%
Sep 30, 202511-45.00%284,018-50.74%45.81%6-25.00%2-33.33%
Jun 30, 202521-12.50%576,4571.50%812.74%8-3-66.67%
Mar 31, 20252420.00%567,926-5.40%813.20%8300.00%912.50%
Dec 31, 20249-60.87%516,536-37.46%66.14%--100.00%3-66.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF117.47K1.71%-
Vanguard Total Stock Mkt Idx Inv95.07K1.40%-24.46K
Vanguard Institutional Extnd Mkt Idx Tr51.47K0.76%-23.45K
Fidelity Extended Market Index41.70K0.61%-294.00
Fidelity Nasdaq Composite Index26.21K0.39%-
Spartan Total Market Index Pool G20.06K0.30%-
Spartan Total Market Index Pool E20.06K0.29%-
Fidelity Total Market Index15.26K0.22%-
NT Ext Equity Mkt Idx Fd - NL14.43K0.21%-
Fidelity Series Total Market Index12.90K0.19%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 07, 2026Silverman Joshua CEO and PresidentBuy$33.32K
Jan 06, 2026Silverman Joshua CEO and PresidentBuy$23.67K
Jan 05, 2026Silverman Joshua CEO and PresidentBuy$23.49K
Jan 07, 2026SCHECHTER JONATHAN-Buy$16.87K
Jan 06, 2026SCHECHTER JONATHAN-Buy$15.81K

Insider Transactions Trends


DateBuySell
2026 Q16-
2025 Q4--
2025 Q2--
2024 Q2--
2023 Q4--

PMCB Ownership FAQ


Who Owns PharmaCyte Biotech?

PharmaCyte Biotech shareholders are primarily institutional investors at 7.59%, followed by 8.56% insiders and 83.85% retail investors. The average institutional ownership in PharmaCyte Biotech's industry, Biotech Stocks , is 382.34%, which PharmaCyte Biotech falls below.

Who owns the most shares of PharmaCyte Biotech?

PharmaCyte Biotech’s largest shareholders are Hrt financial lp (182.8K shares, 2.69%), Geode capital management (123.84K shares, 1.82%), and Renaissance (94.04K shares, 1.38%). Together, they hold 5.90% of PharmaCyte Biotech’s total shares outstanding.

Does Blackrock own PharmaCyte Biotech?

BlackRock is not among the top 10 institutional shareholders of PharmaCyte Biotech.

Who is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested?

Equitec proprietary markets is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 82.73K PharmaCyte Biotech shares, valued at 129.88K$.

Who is the top mutual fund holder of PharmaCyte Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of PharmaCyte Biotech shares, with 1.71% of its total shares outstanding invested in 117.47K PharmaCyte Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools